GB0201498D0 - Materials and methods for treating cancer - Google Patents

Materials and methods for treating cancer

Info

Publication number
GB0201498D0
GB0201498D0 GBGB0201498.3A GB0201498A GB0201498D0 GB 0201498 D0 GB0201498 D0 GB 0201498D0 GB 0201498 A GB0201498 A GB 0201498A GB 0201498 D0 GB0201498 D0 GB 0201498D0
Authority
GB
United Kingdom
Prior art keywords
materials
methods
treating cancer
cancer
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0201498.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotech Research Ventures Pte Ltd
Original Assignee
Biotech Research Ventures Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech Research Ventures Pte Ltd filed Critical Biotech Research Ventures Pte Ltd
Priority to GBGB0201498.3A priority Critical patent/GB0201498D0/en
Publication of GB0201498D0 publication Critical patent/GB0201498D0/en
Priority to CNB038060302A priority patent/CN1325918C/en
Priority to US10/502,470 priority patent/US20060127896A1/en
Priority to PCT/GB2003/000329 priority patent/WO2003062826A2/en
Priority to HK05110342A priority patent/HK1078646A1/en
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells
GBGB0201498.3A 2002-01-23 2002-01-23 Materials and methods for treating cancer Ceased GB0201498D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB0201498.3A GB0201498D0 (en) 2002-01-23 2002-01-23 Materials and methods for treating cancer
CNB038060302A CN1325918C (en) 2002-01-23 2003-01-23 Materials and methods for examining and treating nasopharyngeal carcinoma
US10/502,470 US20060127896A1 (en) 2002-01-23 2003-01-23 Materials and methods for treating cancer
PCT/GB2003/000329 WO2003062826A2 (en) 2002-01-23 2003-01-23 Materials and methods for examining and treating nasopharyngeal carcinoma
HK05110342A HK1078646A1 (en) 2002-01-23 2005-11-18 Materials and methods for examining and treating nasopharyngeal carcinoma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0201498.3A GB0201498D0 (en) 2002-01-23 2002-01-23 Materials and methods for treating cancer

Publications (1)

Publication Number Publication Date
GB0201498D0 true GB0201498D0 (en) 2002-03-13

Family

ID=9929586

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0201498.3A Ceased GB0201498D0 (en) 2002-01-23 2002-01-23 Materials and methods for treating cancer

Country Status (5)

Country Link
US (1) US20060127896A1 (en)
CN (1) CN1325918C (en)
GB (1) GB0201498D0 (en)
HK (1) HK1078646A1 (en)
WO (1) WO2003062826A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005072858A1 (en) 2004-01-26 2005-08-11 President And Fellows Of Harvard College Fluid delivery system and method
US7250416B2 (en) 2005-03-11 2007-07-31 Supergen, Inc. Azacytosine analogs and derivatives
US7998674B2 (en) * 2005-09-22 2011-08-16 China Synthetic Rubber Corporation Gene expression profiling for identification of prognostic subclasses in nasopharyngeal carcinomas
US7700567B2 (en) 2005-09-29 2010-04-20 Supergen, Inc. Oligonucleotide analogues incorporating 5-aza-cytosine therein
CN101104852A (en) * 2006-07-10 2008-01-16 中山大学肿瘤防治中心 Human new gene LOC344967 correlated with nasopharyngeal carcinoma and coding protein product thereof
AU2012302051B2 (en) 2011-08-30 2017-04-27 Astex Pharmaceuticals, Inc. Decitabine derivative formulations
US9588027B2 (en) 2013-03-13 2017-03-07 UPKO Diagnostics, LLC Mixing of fluids in fluidic systems
MX2017007576A (en) 2014-12-12 2018-03-09 Opko Diagnostics Llc Fluidic systems comprising an incubation channel, including fluidic systems formed by molding.
EP3316685A4 (en) 2015-07-02 2019-03-13 Otsuka Pharmaceutical Co., Ltd. Lyophilized pharmaceutical compositions
WO2019025863A2 (en) 2017-08-03 2019-02-07 Otsuka Pharmaceutical Co., Ltd. Drug compound and purification methods thereof
TWI680297B (en) * 2018-07-04 2019-12-21 長庚大學 A method for evaluating whether an individual with cancer suitable for applying anti-cancer drugs
CN113559094A (en) * 2021-08-25 2021-10-29 西北农林科技大学 Application of sodium ascorbate

Also Published As

Publication number Publication date
CN1643377A (en) 2005-07-20
US20060127896A1 (en) 2006-06-15
WO2003062826A3 (en) 2003-10-16
WO2003062826A2 (en) 2003-07-31
CN1325918C (en) 2007-07-11
HK1078646A1 (en) 2006-03-17

Similar Documents

Publication Publication Date Title
EP1565187A4 (en) Methods of treating cancer and related methods
AU2003293194A8 (en) Compositions and methods for treating prostate cancer
AU2003230750A1 (en) Compositions and methods for treating cancer
AU2003284242A8 (en) Methods and compositions for use in treating cancer
EP2671581B8 (en) Compositions and methods for treating cancer
AU2003226301A8 (en) Method of treating cancer
EP1468118A4 (en) Methods and compositions for treating cancer
EP1589990A4 (en) Method for treating cancer in humans
EP1680073A4 (en) Compounds and method for treating cancer
AU2003256847A8 (en) Method of treating cancer
HK1078646A1 (en) Materials and methods for examining and treating nasopharyngeal carcinoma
IL164219A0 (en) Method for treating and preventing hyparathyroidism
EP1572118A4 (en) Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 216
EP1567198A4 (en) Materials and methods for treating ocular-related disorders
AU2003268032A8 (en) Composition and methods for treatment and screening
AU2003212634A8 (en) Compounds useful in the treatment of cancer
EP1626711A4 (en) Compositions and methods for treating cancer
PL379264A1 (en) Compositions and methods for treating cancer using igsf9 and liv-1
EP1401377A4 (en) Methods for treating cancer
AU2003225461A8 (en) Composition and method for supporting cancer treatments
AU2003298708A8 (en) Gpc99 and gpc99a: methods and compositions for treating cancer
EP1684795A4 (en) Methods and agents for the treatment of cancer
AU2002305138A1 (en) Methods and materials for cancer treatment
GB0223325D0 (en) Treating cancer
AU2003295604A8 (en) Gpc15: methods and compositions for treating cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)